Back
91
Day Range
$27.20
$28.29
52-Week Range
$12.91
$42.13
Volume
1,165,403
50D / 200D Avg
$29.58
/
$25.90
Prev Close
$26.84
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -50.9 | 0.4 |
| P/B | 22.3 | 2.9 |
| ROE % | -57.8 | 3.8 |
| Net Margin % | -10.2 | 3.9 |
| Rev Growth 5Y % | 38.9 | 10.0 |
| D/E | 2.9 | 0.2 |
Key Takeaways
Revenue grew 38.90% annually over 5 years — strong growth
Debt/Equity of 2.86 — high leverage
Generating 37.78M in free cash flow
PEG of 0.79 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 71.55%
Capital efficient — spends only 0.00% of revenue on capex
Growth
Revenue Growth (5Y)
38.90%
Revenue (1Y)110.45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-57.80%
ROIC-10.62%
Net Margin-10.24%
Op. Margin-12.80%
Safety
Debt / Equity
2.86
Current Ratio2.74
Interest Coverage-5.85
Valuation
P/E Ratio
-50.93
P/B Ratio22.29
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 110.45% | Revenue Growth (3Y) | 83.81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38.90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 490.73M | Net Income (TTM) | -50.26M |
| ROE | -57.80% | ROA | -8.30% |
| Gross Margin | 85.51% | Operating Margin | -12.80% |
| Net Margin | -10.24% | Free Cash Flow (TTM) | 37.78M |
| ROIC | -10.62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.86 | Current Ratio | 2.74 |
| Interest Coverage | -5.85 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -50.93 | P/B Ratio | 22.29 |
| P/S Ratio | 5.22 | PEG Ratio | 0.79 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.56B | Enterprise Value | 2.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 490.73M | 233.18M | 145.24M | 109.46M | 131.84M |
| Net Income | -50.26M | -321.55M | -111.40M | -278.48M | -180.09M |
| EPS (Diluted) | -0.56 | -4.08 | -1.50 | -4.37 | -3.01 |
| Gross Profit | 419.65M | 225.43M | 133.79M | 105.04M | 128.02M |
| Operating Income | -62.82M | -323.83M | -388.14M | -319.81M | -199.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 605.19M | 594.13M | 788.91M | 672.59M | 776.63M |
| Total Liabilities | 490.36M | 535.05M | 588.10M | 629.73M | 474.52M |
| Shareholders' Equity | 114.83M | 59.08M | 200.81M | 42.85M | 302.11M |
| Total Debt | 328.73M | 401.58M | 404.78M | 407.49M | 261.99M |
| Cash & Equivalents | 93.04M | 58.54M | 58.18M | 61.69M | 165.75M |
| Current Assets | 437.57M | 416.70M | 616.78M | 486.44M | 582.83M |
| Current Liabilities | 159.90M | 200.75M | 177.91M | 142.16M | 124.09M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#1 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026